Fibrosis in Systemic Sclerosis

John A. Varga; Maria Trojanowska

doi:10.1016/j.rdc.2007.11.002

Fibrosis in Systemic Sclerosis

John A. Varga^*, Maria Trojanowska

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Review article › peer-review

67 Scopus citations

Abstract

This article reviews current understanding of the pathophysiology of fibrosis in systemic sclerosis. It highlights recent discoveries, insights, and emerging research, and potential opportunities for the development of targeted antifibrotic therapies.

Original language	English (US)
Pages (from-to)	115-143
Number of pages	29
Journal	Rheumatic Disease Clinics of North America
Volume	34
Issue number	1
DOIs	https://doi.org/10.1016/j.rdc.2007.11.002
State	Published - Feb 2008

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1016/j.rdc.2007.11.002

Cite this

@article{0e0be876916d4ac5b9e18942b7352a57,

title = "Fibrosis in Systemic Sclerosis",

abstract = "This article reviews current understanding of the pathophysiology of fibrosis in systemic sclerosis. It highlights recent discoveries, insights, and emerging research, and potential opportunities for the development of targeted antifibrotic therapies.",

author = "Varga, {John A.} and Maria Trojanowska",

year = "2008",

month = feb,

doi = "10.1016/j.rdc.2007.11.002",

language = "English (US)",

volume = "34",

pages = "115--143",

journal = "Rheumatic Disease Clinics of North America",

issn = "0889-857X",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Fibrosis in Systemic Sclerosis

AU - Varga, John A.

AU - Trojanowska, Maria

PY - 2008/2

Y1 - 2008/2

N2 - This article reviews current understanding of the pathophysiology of fibrosis in systemic sclerosis. It highlights recent discoveries, insights, and emerging research, and potential opportunities for the development of targeted antifibrotic therapies.

AB - This article reviews current understanding of the pathophysiology of fibrosis in systemic sclerosis. It highlights recent discoveries, insights, and emerging research, and potential opportunities for the development of targeted antifibrotic therapies.

UR - http://www.scopus.com/inward/record.url?scp=40149092637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40149092637&partnerID=8YFLogxK

U2 - 10.1016/j.rdc.2007.11.002

DO - 10.1016/j.rdc.2007.11.002

M3 - Review article

C2 - 18329536

AN - SCOPUS:40149092637

SN - 0889-857X

VL - 34

SP - 115

EP - 143

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

IS - 1

ER -

Fibrosis in Systemic Sclerosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this